£495.00

The 2023-2028 Outlook for Rheumatoid Arthritis Treatments in China

Price data last checked 36 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 55 days • 55 data points (No recent data available)

Historical
Generating forecast...
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 26 January 2026 08 February 2026 22 February 2026 07 March 2026 21 March 2026

Price Distribution

Price distribution over 55 days • 1 price levels

Days at Price
55 days 0 14 28 41 55 £495 Days at Price

Price Analysis

Most common price: £495 (55 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 55 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
25 August 2022

Similar Products You Might Like

The 2023-2028 Outlook for Psoriatic Arthritis Treatments in China
98% match

The 2023-2028 Outlook for Psoriatic Arthritis Treatments in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Analgesic Osteoarthritis Treatments in China
98% match

The 2023-2028 Outlook for Analgesic Osteoarthritis Treatments in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in China
96% match

The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Amyloidosis Treatments in China
96% match

The 2023-2028 Outlook for Amyloidosis Treatments in China

£495.00 08 Jan 2026
The 2023-2028 Outlook for Immunology Therapeutics in China
96% match

The 2023-2028 Outlook for Immunology Therapeutics in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Sarcopenia Treatments in China
96% match

The 2023-2028 Outlook for Sarcopenia Treatments in China

£495.00 25 Feb 2026
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in China
96% match

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Plantar Fasciitis Treatments in China
96% match

The 2023-2028 Outlook for Plantar Fasciitis Treatments in China

£495.00 24 Jan 2026
The 2023-2028 Outlook for IBD (Ulcerative Colitis and Crohn's Disease) Treatments in China
96% match

The 2023-2028 Outlook for IBD (Ulcerative Colitis and Crohn's Disease) Treatments in China

£495.00 08 Jan 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in China
96% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in China

£495.00 20 Jan 2026
The 2023-2028 Outlook for Peripheral Neuritis Treatments in China
96% match

The 2023-2028 Outlook for Peripheral Neuritis Treatments in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Joint Health Supplements in China
95% match

The 2023-2028 Outlook for Joint Health Supplements in China

£495.00 13 Dec 2025
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China
95% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China

£495.00 31 Jan 2026
The 2023-2028 Outlook for Glucosamine Nutritional Supplements in China
95% match

The 2023-2028 Outlook for Glucosamine Nutritional Supplements in China

£495.00 10 Feb 2026
The 2023-2028 Outlook for Atopic Dermatitis Treatments in China
95% match

The 2023-2028 Outlook for Atopic Dermatitis Treatments in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in China
95% match

The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in China

£495.00 24 Jan 2026
The 2023-2028 Outlook for Respiratory Disorder Treatments in China
95% match

The 2023-2028 Outlook for Respiratory Disorder Treatments in China

£495.00 13 Jan 2026
The 2023-2028 Outlook for Diabetic Retinopathy Treatments in China
95% match

The 2023-2028 Outlook for Diabetic Retinopathy Treatments in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in China
95% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Peripheral Neuropathy Treatments in China
95% match

The 2023-2028 Outlook for Peripheral Neuropathy Treatments in China

£495.00 13 Jan 2026
The 2023-2028 Outlook for Hydroxychloroquine Sulphates in China
95% match

The 2023-2028 Outlook for Hydroxychloroquine Sulphates in China

£495.00 01 Feb 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
95% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in China

£495.00 25 Jan 2026
The 2023-2028 Outlook for Eye Allergy Treatments in China
95% match

The 2023-2028 Outlook for Eye Allergy Treatments in China

£495.00 28 Jan 2026
The 2023-2028 Outlook for Scleroderma Diagnostics and Therapeutics in China
95% match

The 2023-2028 Outlook for Scleroderma Diagnostics and Therapeutics in China

£495.00 23 Mar 2026